BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao Y, Li X, Zhang W, Yu L, Wang Y, Deng Z, Liu M, Mo S, Wang R, Zhao J, Liu S, Hao Y, Wang X, Ji T, Zhang L, Wang C. Trends in the biological functions and medical applications of extracellular vesicles and analogues. Acta Pharm Sin B 2021;11:2114-35. [PMID: 34522580 DOI: 10.1016/j.apsb.2021.03.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Zheng W, Tan W, Wu X, Dai Z, Li Z, Yan Z, Ji Y, Wang Y, Su W, Zhong S, Li Y, Sun Y, Li S, Huang W. Injectable MMP1-sensitive microspheres with spatiotemporally controlled exosome release promote neovascularized bone healing. Acta Biomater 2023;157:321-36. [PMID: 36481504 DOI: 10.1016/j.actbio.2022.11.065] [Reference Citation Analysis]
2 Gao F, Mao X, Wu X. Mesenchymal stem cells in osteoarthritis: The need for translation into clinical therapy. Progress in Molecular Biology and Translational Science 2023. [DOI: 10.1016/bs.pmbts.2023.02.006] [Reference Citation Analysis]
3 Dumontel B, Susa F, Limongi T, Vighetto V, Debellis D, Canta M, Cauda V. Nanotechnological engineering of extracellular vesicles for the development of actively targeted hybrid nanodevices. Cell Biosci 2022;12:61. [DOI: 10.1186/s13578-022-00784-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Alberti G, Russo E, Corrao S, Anzalone R, Kruzliak P, Miceli V, Conaldi PG, Di Gaudio F, La Rocca G. Current Perspectives on Adult Mesenchymal Stromal Cell-Derived Extracellular Vesicles: Biological Features and Clinical Indications. Biomedicines 2022;10:2822. [DOI: 10.3390/biomedicines10112822] [Reference Citation Analysis]
5 Zhang W, Jiang Y, He Y, Boucetta H, Wu J, Chen Z, He W. Lipid carriers for mRNA delivery. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.11.026] [Reference Citation Analysis]
6 Meng L, Liao X, Wang Y, Chen L, Gao W, Wang M, Dai H, Yan N, Gao Y, Wu X, Wang K, Liu Q. Pharmacologic therapies of ARDS: From natural herb to nanomedicine. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.930593] [Reference Citation Analysis]
7 Nguyen TH, Dao HH, Duong CM, Nguyen X, Hoang DH, Do X, Truong TQ, Nguyen TD, Nguyen LT, Than UTT. Cytokine-primed umbilical cord mesenchymal stem cells enhanced therapeutic effects of extracellular vesicles on osteoarthritic chondrocytes. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1041592] [Reference Citation Analysis]
8 Zhao M, Wang R, Yang K, Jiang Y, Peng Y, Li Y, Zhang Z, Ding J, Shi S. Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.10.019] [Reference Citation Analysis]
9 Ramírez-pavez T, García-peñaranda A, Garcia-ibañez P, Yepes-molina L, Carvajal M, Ruiz-alcaraz AJ, Moreno DA, García-peñarrubia P, Martínez-esparza M. Potential of Sulforaphane and Broccoli Membrane Vesicles as Regulators of M1/M2 Human Macrophage Activity. IJMS 2022;23:11141. [DOI: 10.3390/ijms231911141] [Reference Citation Analysis]
10 Wang X, Li C, Wang Y, Chen H, Zhang X, Luo C, Zhou W, Li L, Teng L, Yu H, Wang J. Smart drug delivery systems for precise cancer therapy. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.08.013] [Reference Citation Analysis]
11 Zhang E, Phan P, Zhao Z. Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.08.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ren YZ, Ding SS, Jiang YP, Wen H, Li T. Application of exosome-derived noncoding RNAs in bone regeneration: Opportunities and challenges. World J Stem Cells 2022;14:473-89. [PMID: 36157529 DOI: 10.4252/wjsc.v14.i7.473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zoulikha M, Xiao Q, Boafo GF, Sallam MA, Chen Z, He W. Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome. Acta Pharm Sin B 2022;12:600-20. [PMID: 34401226 DOI: 10.1016/j.apsb.2021.08.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 23.0] [Reference Citation Analysis]
14 Gültekin HE, Oner E, İlhan M, Karpuz M. Nanovesicles for intravenous drug delivery. Applications of Nanovesicular Drug Delivery 2022. [DOI: 10.1016/b978-0-323-91865-7.00018-3] [Reference Citation Analysis]
15 Chen C, Wang J, Sun M, Li J, Wang HD. Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery. Biomed Pharmacother 2021;145:112416. [PMID: 34781147 DOI: 10.1016/j.biopha.2021.112416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Papukashvili D, Rcheulishvili N, Liu C, Xie F, Tyagi D, He Y, Wang PG. Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy. Cells 2021;10:2957. [PMID: 34831180 DOI: 10.3390/cells10112957] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lv Y, He W, Wu W. Editorial of Special Issue of Hot Topic Reviews in Drug Delivery. Acta Pharm Sin B 2021;11:2094-5. [PMID: 34522578 DOI: 10.1016/j.apsb.2021.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]